Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Landeskrankenhaus Salzburg, also known as the University Hospital Salzburg, is the largest medical facility in the state of Salzburg, Austria, and serves as the primary teaching hospital for Paracelsus Medical University. As part of the Salzburger Landeskliniken (SALK) group, it provides a comprehensive range of specialized healthcare services, including advanced oncology, cardiology, and neurology. The institution is a major hub for clinical research in Europe, hosting numerous Phase I-III clinical trials in collaboration with global pharmaceutical and biotechnology companies. With state-of-the-art diagnostic and therapeutic infrastructure, it integrates academic excellence with high-quality patient care. The hospital plays a critical role in the regional healthcare system, serving both the local population and international patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Landeskrankenhaus Salzburg.